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The impact of radiation dose exposure during
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Claire Jones, MB BCh, MRCS, Stephen A. Badger, MD, MRCS, Christopher S. Boyd, MD, FRCR, and
Chee V. Soong, MD, FRCS, Belfast, Ireland
Objective: Endovascular aneurysm repair (EVAR) exposes patients to radiation during the procedure and in subsequent
follow-up. The study goal was to calculate the radiation dose in our unit and compare it against other published data and
national guidelines.
Methods: All EVAR procedures were identified from a prospectively maintained database. Radiation dose, screening time,
and volume of intravenous contrast during the procedure were reviewed. Radiation exposure from subsequent computed
tomography (CT) imaging was included in the overall exposure. Results are expressed as mean  standard deviation.
Results: From October 1998 to October 2008, 320 elective patients underwent EVAR. Mean screening time was 29.4 
23.3 minutes, and the radiation dose was 11.7  7.1 mSv. The EVAR was an emergency in 64 patients. The mean
screening time was 22.9 18.2 minutes, and the radiation dose was 13.4 8.6 mSv. During the first postoperative year,
follow-up CT scans exposed the patients to 24.0 mSv, with 8.0 mSv in subsequent years. Abdominal radiographs added
an additional 1.8 mSv each year.
Conclusion: EVAR and the follow-up investigations involve substantial amounts of radiation, with well-recognized
carcinogenic risks. Because patient safety is paramount, radiation exposure should be minimized. This may be possible by
standardizing radiation exposure throughout the United Kingdom by implementing national guidelines and considering
other imaging modalities for follow-up. (J Vasc Surg 2010;52:298-302.)Vascular surgery has evolved significantly in recent
years with the introduction of endovascular procedures.
Endovascular aortic aneurysm repair (EVAR) was first re-
ported in 1991 and has now become an integral part of
vascular surgery as an established less invasive treatment
option for the repair of abdominal aortic aneurysms
(AAA).1-4 The benefits to the patient are apparent, with a
two-thirds reduction in 30-day operative mortality. Other
benefits include a reduction in perioperative blood loss,
shorter procedure time, less time spent in the intensive are
unit postoperatively, and an overall shorter hospital length
of stay.2-4
The use of fluoroscopy is common in endovascular
procedures, which therefore raises the issue of patient ex-
posure to potentially harmful radiation. To minimize intra-
operative radiation exposure, some units practice intravas-
cular ultrasound imaging, without angiography, reporting
similar outcomes to those exposed to angiography.5 Most,
however, regard ultrasound imaging as an adjuvant to
ensure direct apposition of the stent graft to the proximal
landing zone rather than as a sole imaging modality.
The short-term adverse effects of radiation exposure
include skin erythema, cataracts, permanent epilation, and
delayed skin necrosis, whereas the long-term risks may
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298include cancer of the thyroid, central nervous system, skin,
and breast.6-9 Although radiologic imaging is essential for
EVAR, the radiation exposure should be limited, particu-
larly in view of the carcinogenic potential, to a lifetime
cumulative total of 400 mSv. A recent study found a
13-fold variation between the highest and lowest effective
radiation dose for the same imaging technique within and
across institutions, highlighting the variation of radiation
exposure and the need for standardization.10
EVAR can be performed in a dedicated angiographic
suite, where the images may be better, or more commonly
in an operating theater using a portable C-arm image
intensifier. Although the difference in radiation dose be-
tween the two systems is not significant, the latter tends to
produce a less focused beam, with wider scatter of x-rays.
Individual patients do not suffer, but the endovascular team
may be at higher risk.
The goal of this study was to determine radiation
exposure to the patient while undergoing an EVAR by
measuring the radiation effective dose and screening time
for each procedure, and also in the follow-up period, and
then to compare the standards of our unit with other
published data to ensure patient safety is not being com-
promised.
METHODS
Patients. All patients who had undergone EVAR in
the Belfast City Hospital for an AAA were retrospectively
identified. Elective patients had an AAA with a maximum
diameter of 55 mm. Patients undergoing emergency
EVAR were similar but with radiologic evidence of leak or
rupture. The endovascular database, theatre logs, and the
records of the endovascular suite were used to capture all
patients who underwent EVAR.
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by computed tomography (CT) to ensure appropriate se-
lection of anatomically suitable aneurysms based on widely
accepted anatomic criteria.11 Although angiography may
have been performed after CT, it was not used as the
modality for EVAR planning or patient selection.12 The
total number of aneurysm repairs increased in our unit
during the study, and the proportion undergoing EVAR
increased from 22% in 1999 to 53% in 2008. Customized
bifurcated stent grafts from a variety of different manufac-
turers were deployed in elective patients under radiologic
guidance. The data recorded included:
● the screening time, which is the time duration of the
procedure;
● the radiation dose, which measures the dose of radia-
tion that strikes the x-ray film behind the patient and
turns the x-ray system off when the predetermined
dose for that screen-film combination has been
reached; and
● the volume of intravenous contrast required.
From this was calculated the effective radiation dose, which
expresses the dose and the volume of tissue irradiated, and
therefore the amount of radiation the patient absorbs.
All emergency patients underwent preoperative CT
confirmation of AAA with intravenous contrast extravasa-
tion. Those who had a symptomatic AAA with no extrava-
sation were included in the elective group of this study. In
emergency patients a uniiliac aortic stent graft was deployed
with contralateral iliac occlusion. This was usually per-
formed under local anaesthetic, but to achieve hemody-
namic control by aneurysm exclusion, the subsequent
femorofemoral crossover graft was performed under a brief
general anesthetic. The placement of a contralateral occlu-
sive device is usually rapid and requires only one angio-
graphic run, thus only increasing the radiation dose
slightly. Similar radiation data were also recorded for these
patients.
Nearly all emergency and most elective procedures
were performed in an operating theater and a portable
C-arm was used, although some elective cases in the initial
years were performed in the angiography suite. There was
no update in the equipment during the study period.
The details of the surgical procedures have been de-
scribed before.13,14 Patients who had moderate renal dys-
function were given intravenous fluids before EVAR or
follow-up CT. Those with severe dysfunction were given
N-acetylcysteine in addition to fluid. There was no differ-
ence in operative strategy.
Data collection and analysis. The radiation data of all
primary elective and emergency procedures were collected
and compiled in Excel (Microsoft Corp, Redmond, Wash).
Secondary interventions directly related to the EVAR were
also identified and included in the database. All patients
routinely had a CT preoperatively and then during postop-
erative follow-up at 1, 3, and 12 months and annually
thereafter, according to the protocol of the EVAR trials.2,3Annual abdominal x-ray (AXR) imaging was performedwith anteroposterior and 45° oblique projections to look
for structural integrity or component separation. Although
AAA patients often have other cardiovascular diseases, the
radiation exposure during coronary and peripheral vascular
procedures was not included because it was not within the
remit of the study.
The average and distribution of the angiographic
screening time in minutes, radiation dose (Gycm2), and
intravenous contrast volume (mL) were expressed in mean
and standard deviation. The radiation dose was routinely
recorded in Gycm.2 However, this was converted to an
effective dose equivalent (mSv) that was used to compare
radiation doses on different body parts on an equivalent
basis using the conversion factor of 0.25 mSv/Gycm,2 as
demonstrated in previous guidelines.15 The radiation dose
affecting the radiologist and surgeon was not assessed in
this study because routine use of radiation counters would
be required, preferably in a prospective study.
The radiation exposure of an average CT was taken to
be 500 mGycm, or by using the multiplication conversion
factor of 0.015 mSv/mGycm, the effective dose was as-
sumed to be 8.0 mSv. Two abdominal radiographs exposed
the patient to 6.0 mGy each, which using a conversion
factor of 0.15 mSv/mGy gave a total effective dose of 1.8
mSv.15-17 The radiation dose per CT and AXR were incor-
porated into the calculations of total radiation exposure.
A 4-slice CT scanner was initially used in our unit,
whereas in latter years, a 16-slice scanner was used. This was
not considered to be a source of variability because the
faster, modern multislice scanners may actually result in
lower radiation owing to the decreased overlapping pen-
umbral radiation zones.18 Although the figures used in this
study may not be accurate for every type of CT scanner,
depending upon make and age, they were used to allow a
wider application of the results beyond our own unit and
can be modified according to local scanners.
The conversion of all measurements to mSv allowed
cumulative calculations to be made. Although no specific
guidelines are available for EVAR radiation exposure, the
results of the study were compared with other similar
studies in the published literature and general guidelines for
radiation exposure.
RESULTS
Elective EVAR patients. Between October 1, 1998,
andOctober 31, 2008, 320 patients (270men, 50 women)
underwent a primary EVAR. Their average age was 75.3
7.0 years. A variety of stent grafts were used, including Ana-
conda (Sulzer Vascutech, Bad Soden, Germany) in 3, Anson
(Lombard Medical Technologies, Didcot, UK) in 12, Aorfix
(Lombard) in 5, Cook (Cook, Bloomington, Ind) in 49,
Endurant (Medtronic, Minneapolis, Minn) in 6, Gore (W. L.
Gore and Assoc, Flagstaff, Ariz) in 3, and Vanguard (Boston
Scientific Corp, Natick Mass) in 3. A Talent (Medtronic,
Sunnyvale, Calif) stent graft was used in the remaining pa-
tients. In 30 patients, a balloon-expandable Palmaz (Cordis,
Miami Lakes, Fla) stent graft was required in addition to
the primary stent graft during the initial repair.
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23.3 minutes, and the radiation dose was 46.9  28.4
Gycm.2 The effective dose was calculated as 11.7 7.1 mSv
(range, 0.3-51.2mSv). During the procedures, 163.9 67.7
mL of intravenous contrast was required. The correlations
between the screening time and radiation dose (r  0.46,
P  .0001) and contrast volume (r  0.45, P  .0001),
although statistically significant, were only moderate. The
correlation between radiation dose and contrast volume
was similar (r  0.42, P  .00001). The effective dose of
preoperative CT, EVAR, and postoperative surveillance for
the first year was a mean total of 45.5 mSv.
An additional 25 secondary procedures were required
in a subgroup of 22 patients. The rate of secondary proce-
dures declined with time. The indication was an endoleak in
14 and stent graftmigration in 11.This added another 24.0
21.3 minutes of screening time, 31.8  29.7 Gycm2 of
radiation (7.9  7.4 mSV), and 10.3  5.5 mL of intrave-
nous contrast was used.
Emergency EVAR patients. During the same period,
64 patients (55 men, 9 women) underwent stent graft
insertion as an emergency for AAA. Their average age was
75.5  7.5 years. Two patients underwent Zenith (Cook,
Bloomington, Ind) stent graft placement to gain control of
their AAA, and Talent stent grafts were used in the remain-
ing patients. During their primary repair, 15 patients also
required a balloon-expandable Palmaz stent graft during
their primary repair.
The screening time was 22.9  18.2 minutes, and the
radiation dose was 53.8  34.6 Gycm.2 The effective dose
was calculated as 13.4  8.6 mSv (range 1.0-41.0 mSv).
The average contrast volume was 187.1  98.1 mL. The
correlation between screening time and radiation dose (r
0.49, P  .0002) and contrast volume (r  0.53, P 
.0001) was similarly moderate in emergencies, although
better correlation was seen between the radiation dose and
Table. The radiation dose (in mSv) over time as a result o
Time Group EVAR
Preop Elective
Emergency
Postop Elective 11.7
Emergency 13.4
Year(s)
1 Elective 2
Emergency 2
5 Elective 3
Emergency 3
10 Elective 4
Emergency 4
15 Elective 4
Emergency 4
20 Elective 4
Emergency 4
25 Elective 4
Emergency 4
AXR, Abdominal x-ray; CT, computed tomography.contrast volume (r  0.61, P  .0001). The lack ofstrength in correlation between screening time and radia-
tion dose is due to the variable proportions within a proce-
dure of single fluoroscopic images and digital subtraction
angiographic runs, which have a higher dose. These pro-
portions had not been recorded separately and may vary
between primary and secondary operations and between
elective and emergency procedures. The effective dose of
radiation in preoperative CT, EVAR, and postoperative
surveillance for the first year was a mean total of 47.2 mSv.
Four patients underwent an additional secondary inter-
vention. The indication was endoleak in one and migration
in three. These had an average screening time of 21.5 
20.2 minutes, with a radiation dose of 49.9 42.6 Gycm2
(12.5  1.1 mSv) and contrast volume of 106.2  59.8
mL. The effective dose was calculated as 8.4  7.1 mSv.
Long-term follow-up. The total radiation doses
(mSv) for elective and emergency patients as a result of the
EVAR procedure and preoperative and postoperative CT
and AXR are reported in the Table. This calculation as-
sumed that all patients complied with the same recom-
mended postoperative follow-up from this unit, which was
CT at 1, 3, and 12 months and annually thereafter, along
with annual AXR, in accordance with the protocol of the
EVAR trials. Radiation exposure is nonsignificantly greater
in emergency patients due to the slightly higher dose
intraoperatively; however, radiation exposure thereafter is
assumed to be the same. For simplicity and because of the
small number of patients involved, the risk of secondary
intervention was not included, although this would in-
crease exposure further due to the intraoperative dose and
as a result of the patient reverting back to the first-year
schedule of three CT scans after any intervention.
DISCUSSION
This study assessed radiation exposure during EVAR
and in the follow-up, although currently, no national
ergoing endovascular aneurysm repair (EVAR)
AXR Total Cumulative total
8.0 8.0
8.0 8.0
11.7 19.7
13.4 21.4
1.8 25.8 45.5
1.8 25.8 47.2
7.2 39.2 84.7
7.2 39.2 86.4
9.0 49.0 1133.7
9.0 49.0 135.4
9.0 49.0 182.7
9.0 49.0 184.4
9.0 49.0 231.7
9.0 49.0 233.4
9.0 49.0 280.7
9.0 49.0 282.4f und
CT
8.0
8.0
4.0
4.0
2.0
2.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0guidelines are available regarding radiation exposure with
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strengths. Firstly, it has the largest patient cohort in the
literature to date, during a 10-year period. Secondly, the
consideration of radiation exposure in emergency repairs,
which is becoming increasingly common, has not been
previously reported to our knowledge. Finally, the incor-
poration of preoperative and postoperative radiographic
imaging helps to provide an overall impression of radiation
exposure associated with EVAR.
Radiation exposure is a risk factor for developing cancer
but is associated with a latency period of between 10 and 20
years.6 The mean age of patients in this study of 75 years
represents most EVAR patients, and therefore, this risk may
not be of significant clinical importance. The other associ-
ated risk of radiation exposure is acute skin injury, which is
usually seen with skin doses 2 Gy.6 Imaging equipment
can be adapted to reduce this by using a heavy copper
infiltration beam in the mobile C arm, resulting in a rela-
tively low output. With these recognized dangers therefore
in mind, it reinforces the importance of monitoring the
radiation exposure involved in EVAR, with patient safety
being paramount.
The screening time within this present study compares
favorably with other smaller studies of 24 and 12 patients,
which reported average screening times of 28 in elective
cases and 20.6 minutes in emergency cases.19,20 The effec-
tive radiation dose in elective patients also is comparable
with other published data of 10.5 mSv.19 One weakness in
our results is the lack of recorded data on patient weight
and body mass index, because obese patients require in-
creased radiation to maintain image quality.20 Therefore,
any prospective trial should incorporate this variable into
the study design and statistical model with the use of
patient radiation counters.
The different stent grafts that were used might have
influenced the three radiologic parameters. Although a
Talent device was used in 97% of emergency procedures,
this proportion dropped to 75% in elective repairs. A lack of
familiarity in the occasional use of other devices may result
in longer repair times and higher radiation doses in these
patients, but the wide experience of the unit in EVAR
should more than compensate for this additional variable.
The radiation exposure of secondary procedures has
not been incorporated into the cumulative data during the
follow-up years. This is because although it influenced the
results for those individuals, most of the secondary inter-
ventions were performed on a small number of patients
who sometimes required repeated procedures; therefore,
the patients would not be representative of the overall
cohort and their results not widely applicable.
Elective EVARs were commenced in the vascular unit
before emergency repairs were attempted, therefore gain-
ing sufficient experience before the first emergency repair.
Although the screening time was lower, reflecting differing
surgical strategies, the radiation dose and contrast volumes
were higher, suggesting that less emphasis was placed upon
radiation reduction in emergency EVARs. Patients present-
ing with ruptured AAA have a higher morbidity and mor-tality rates than patients undergoing elective repair. How-
ever, because EVAR for rupture has a lower morbidity and
mortality than open repair, it would be reasonable to accept
this higher radiation exposure in these patients without
implying any compromise of patient safety.21 Thus, this
study further strengthens the argument in favor of EVAR of
emergency patients, where anatomically suitable.
Weerakkody et al22 demonstrated a mean effective ra-
diation dose of 79 mSv during a 1-year period, including
EVAR and follow-up.We have reported an effective dose of
45.5 mSv in a 1-year follow-up, which included preopera-
tive investigations, the procedure, and 1 year of surveillance
for elective patients. The benefit in exposing patients to
further postoperative radiation is questionable. A recent
study of 304 patients with a total of 1167 CT scans dem-
onstrated that only 9.3% of patients benefitted from post-
operative follow-up CT scanning as abnormalities that re-
quired further intervention were detected in otherwise
asymptomatic patients.23 In the presence of a normal CT
result at 1 month, there was no benefit to the patient to
undergo a further CT until the scan at 1 year.24
To avoid excessive radiation, follow-up of EVAR pa-
tients using a different imaging modality may be appropri-
ate. Duplex ultrasound imaging has a sensitivity of 86% to
detect endoleaks and a specificity of 67% due to a large
number of false-positives.25 It can determine graft patency
and sac size as well as determine postoperative complica-
tions of EVAR that require reintervention, with the recog-
nized benefits of reduced cost and radiation exposure.26
Thus, the accuracy of duplex imaging may negate the
requirement for regular CT, particularly for type II en-
doleaks in the presence of decreasing sac size.27 Although
type I and III endoleaks may require intervention, further
research into flow characteristics of type II endoleak may
allow patient selection for reintervention to be decided on
duplex criteria. This alternative follow-up option may be
especially relevant in younger patients to reduce the long-
term carcinogenic risks of radiation exposure but is less
pertinent for older patients because of the recognized la-
tency period.28 The protocol of our unit is under review to
commence utilization of duplex imaging and AXR as the
sole follow-up rather than annual CT scans.
CONCLUSIONS
EVAR and the follow-up investigations involve sub-
stantial amounts of radiation, with well-recognized carci-
nogenic risks. Because patient safety is paramount, radia-
tion exposure should be minimized. This may be possible
by standardizing radiation exposure throughout the
United Kingdom by the implementation of national guide-
lines, along with considering other imaging modalities for
follow-up.
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